News & Perspective

Mar 30, 2012

Mar 30, 2012

NSABB reverses recommendation on H5N1 studies

(CIDRAP News) – A federal advisory board today reversed its stance on publishing two controversial H5N1 transmission papers today, recommending that both studies be published in full.

The National Science Advisory Board for Biosecurity (NSABB) met yesterday and today to discuss revised versions of the studies by two groups, one from the University of Wisconsin, Madison, and one from Erasmus University in the Netherlands.

Mar 30, 2012

US flu activity shows signs of ebbing

(CIDRAP News) – Influenza activity in the United States—while never very high this season—showed signs of decline in data reported today by the Centers for Disease Control and Prevention (CDC).

Mar 30, 2012

Pet turtles linked to three Salmonella outbreaks in 16 states

(CIDRAP News) – The US Centers for Disease Control and Prevention (CDC) today announced three Salmonella outbreaks linked to pet turtles that have sickened 66 people in 16 states so far.

Trace-back investigations found that turtles with shells less than 4 inches long or their environments are the cause of the outbreaks. Two of the outbreaks appear to involve red-eared slider turtles.

Mar 29, 2012

Mar 29, 2012

US debuts life sciences dual-use research policy

(CIDRAP News) – Federal health officials today unveiled a new policy for overseeing life sciences dual-use research, such as two recent H5N1 transmission studies that have sparked bioterror concerns as well as cries of censorship.

Mar 29, 2012

Studies confirm H1N1 vaccine-narcolepsy link in Finnish kids

(CIDRAP News) – Two studies yesterday confirmed the link between narcolepsy in Finnish children and the adjuvanted 2009 H1N1 pandemic vaccine Pandemrix and offered new details.

Pages

Sort Results

 

Narrow results

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»